Genprex (GNPX) Short Interest Ratio & Short Volume $0.18 -0.02 (-9.84%) As of 11:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Genprex Short Interest DataGenprex (GNPX) has a short interest of 4.13 million shares, representing 9.88% of the float (the number of shares available for trading by the public). This marks a 49.64% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 5.08 million shares to cover all short positions.Current Short Interest4,130,000 sharesPrevious Short Interest2,760,000 sharesChange Vs. Previous Month+49.64%Dollar Volume Sold Short$1.14 millionShort Interest Ratio0.5 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares42,905,000 sharesFloat Size41,790,000 sharesShort Percent of Float9.88%Today's Trading Volume755,398 sharesAverage Trading Volume5,081,471 sharesToday's Volume Vs. Average15% Short Selling Genprex? Sign up to receive the latest short interest report for Genprex and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNPX Short Interest Over TimeGNPX Days to Cover Over TimeGNPX Percentage of Float Shorted Over Time Genprex Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20254,130,000 shares $1.14 million +49.6%9.9%0.5 $0.28 8/31/20252,760,000 shares $452.64 thousand +43.0%8.5%0.3 $0.16 8/15/20251,930,000 shares $409.55 thousand +40.9%5.9%0.5 $0.21 7/31/20251,370,000 shares $316.47 thousand +64.2%4.2%0.7 $0.23 7/15/2025834,400 shares $247.48 thousand -74.9%2.6%0.3 $0.30 6/30/20253,320,000 shares $756.63 thousand +44.4%10.3%1.3 $0.23 6/15/20252,300,000 shares $671.37 thousand -7.6%8.2%0.5 $0.29 5/31/20252,490,000 shares $883.95 thousand +69.4%9.2%0.5 $0.36 5/15/20251,470,000 shares $348.10 thousand -42.6%5.4%0.3 $0.24 4/30/20252,560,000 shares $742.40 thousand +57.1%10.9%0.6 $0.29 Get the Latest News and Ratings for GNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter. 4/15/20251,630,000 shares $423.80 thousand +487.6%6.9%0.4 $0.26 3/31/2025277,400 shares $68.05 thousand -16.9%1.2%0.1 $0.25 3/15/2025333,600 shares $121.20 thousand -47.3%4.0%0.2 $0.36 2/28/2025633,100 shares $238.68 thousand -44.0%7.7%0.7 $0.38 2/15/20251,130,000 shares $498.22 thousand +505.3%13.7%1.2 $0.44 1/31/2025186,700 shares $115.49 thousand -28.6%2.3%0.2 $0.62 1/15/2025261,300 shares $182.91 thousand -34.0%3.2%0.1 $0.70 12/31/2024396,100 shares $337.32 thousand -37.6%4.8%0 $0.85 12/15/2024634,600 shares $736.14 thousand +46.5%7.7%0.1 $1.16 11/30/2024433,100 shares $472.08 thousand +26.6%5.4%0 $1.09 11/15/2024342,100 shares $547.36 thousand -5.9%4.3%0 $1.60 10/31/2024363,400 shares $817.65 thousand +326.5%15.0%0 $2.25 10/15/202485,200 shares $28.49 thousand +5.2%3.5%0 $0.33 9/30/202481,000 shares $29.30 thousand -66.9%3.3%0.2 $0.36 9/15/2024244,700 shares $102.77 thousand +501.2%9.6%0.6 $0.42 8/31/202440,700 shares $27.87 thousand -83.6%1.6%0.1 $0.68 8/15/2024247,400 shares $161.28 thousand +430.9%9.7%1.1 $0.65 7/31/202446,600 shares $78.29 thousand -16.6%2.3%0.5 $1.68 7/15/202455,900 shares $111.80 thousand +10.5%2.7%0.6 $2.00 6/30/202450,600 shares $95.38 thousand -39.2%2.5%0.5 $1.89 6/15/202483,200 shares $180.54 thousand +75.9%4.0%0.8 $2.17 5/31/202447,300 shares $147.10 thousand +20.1%2.3%0.4 $3.11 5/15/202439,400 shares $96.14 thousand -21.2%1.9%0.8 $2.44 4/30/202450,000 shares $113.00 thousand +0.6%2.5%0.9 $2.26 4/15/202449,700 shares $119.28 thousand -29.0%2.7%0.6 $2.40 3/31/202470,000 shares $208.60 thousand -12.8%3.8%0.8 $2.98 3/15/202480,300 shares $324.41 thousand +23.7%5.6%1 $4.04 2/29/202464,900 shares $279.07 thousand -35.3%4.5%1 $4.30 2/15/2024100,300 shares $439.31 thousand +86.1%6.9%2 $4.38 1/31/202453,900 shares $409.64 thousand +38.6%3.7%1.1 $7.60 1/15/20241,560,000 shares $339.77 thousand +13.9%N/A4.2 $0.22 12/31/20231,370,000 shares $315.10 thousand +25.7%N/A3.6 $0.23 12/15/20231,090,000 shares $229.99 thousand -7.6%N/A3.3 $0.21 11/30/20231,180,000 shares $285.56 thousand -11.9%N/A4 $0.24 11/15/20231,340,000 shares $348.40 thousand -18.3%N/A4.5 $0.26 10/31/20231,640,000 shares $362.44 thousand -8.9%N/A4.2 $0.22 10/15/20231,800,000 shares $585 thousand +9.1%N/A4.2 $0.33 9/30/20231,650,000 shares $651.59 thousand -6.8%N/A3.1 $0.39 9/15/20231,770,000 shares $901.82 thousand +3.5%N/A2.5 $0.51 8/31/20231,710,000 shares $888.69 thousand -19.0%N/A2.4 $0.52 8/15/20232,110,000 shares $1.19 million -17.3%N/A2.8 $0.57 7/31/20232,550,000 shares $1.94 million +11.8%N/A3.9 $0.76 7/15/20232,280,000 shares $1.88 million -22.5%N/A3.8 $0.82 6/30/20232,940,000 shares $2.79 million +55.6%N/A4.7 $0.95 6/15/20231,890,000 shares $1.61 million -6.0%N/A4.5 $0.85 5/31/20232,010,000 shares $1.73 million +6.9%N/A4.4 $0.86 5/15/20231,880,000 shares $1.52 million -16.8%N/A3.4 $0.81 4/30/20232,260,000 shares $1.85 million +37.0%N/A4.1 $0.82 4/15/20231,650,000 shares $1.37 million -4.1%N/A3 $0.83 3/31/20231,720,000 shares $1.57 million -11.3%N/A5 $0.91 3/15/20231,940,000 shares $1.60 million -29.2%N/A4.8 $0.83 2/28/20232,740,000 shares $3.51 million +52.2%N/A7.5 $1.28 2/15/20231,800,000 shares $2.86 million +2.9%N/A5.7 $1.59 1/31/20231,750,000 shares $2.57 million +6.1%N/A9.4 $1.47 1/15/20231,650,000 shares $2.36 million +13.0%N/A9.6 $1.43 12/30/20221,460,000 shares $2.12 million -2.0%N/A8.7 $1.45 12/15/20221,490,000 shares $1.77 million -4.5%N/A13.9 $1.19 11/30/20221,560,000 shares $2.11 million +0.7%N/A15.8 $1.35 11/15/20221,550,000 shares $2.09 million -1.9%N/A12.8 $1.35 10/31/20221,580,000 shares $2.15 million -1.9%N/A6.1 $1.36 10/15/20221,610,000 shares $2.14 million -8.0%N/A6 $1.33 9/30/20221,750,000 shares $2.47 million -0.6%N/A6.7 $1.41 9/15/20221,760,000 shares $2.94 million -5.4%N/A6.8 $1.67 8/31/20221,860,000 shares $2.98 million +16.3%N/A7.2 $1.60 8/15/20221,600,000 shares $3.34 million -4.2%N/A6.6 $2.09 7/31/20221,670,000 shares $2.32 million -11.6%N/A15.1 $1.39 7/15/20221,890,000 shares $2.72 million +1.1%N/A16.3 $1.44 6/30/20221,870,000 shares $2.60 million +2.2%N/A13.9 $1.39 6/15/20221,830,000 shares $2.49 million -9.9%N/A12 $1.36 5/31/20222,030,000 shares $2.98 million +5.2%N/A10.1 $1.47 5/15/20221,930,000 shares $2.93 million -1.0%N/A7 $1.52 4/30/20221,950,000 shares $3.12 million -3.0%N/A5.6 $1.60 4/15/20222,010,000 shares $4.00 million +8.1%N/A3.5 $1.99 3/31/20221,860,000 shares $4.20 million -3.1%N/A1.4 $2.26 3/15/20221,920,000 shares $3.88 million -20.0%N/A0.3 $2.02 2/28/20222,400,000 shares $5.47 million -19.2%N/A0.4 $2.28 2/15/20222,970,000 shares $7.01 million -13.2%N/A0.5 $2.36 1/31/20223,420,000 shares $6.81 million -23.8%N/A0.6 $1.99 1/15/20224,490,000 shares $10.15 million +113.8%N/A0.7 $2.26 12/31/20212,100,000 shares $2.75 million -3.7%N/A0.4 $1.31 12/15/20212,180,000 shares $2.83 million -1.4%N/A5.1 $1.30 11/30/20212,210,000 shares $3.20 million -2.6%N/A5.4 $1.45 11/15/20212,270,000 shares $4.65 million -0.9%N/A5.7 $2.05 10/29/20212,290,000 shares $5.34 million +2.7%N/A6.1 $2.33 10/15/20212,230,000 shares $5.37 million -2.6%N/A5.7 $2.41 9/30/20212,290,000 shares $6.14 million -2.6%N/A6 $2.68 9/15/20212,350,000 shares $6.51 million +2.6%N/A4.8 $2.77 8/31/20212,290,000 shares $7.21 million -2.6%N/A4.3 $3.15 8/13/20212,350,000 shares $6.49 million -10.0%N/A4.1 $2.76 7/30/20212,610,000 shares $7.73 million -6.5%N/A4.5 $2.96 7/15/20212,790,000 shares $8.15 million No Change6.6%4.5 $2.92 6/30/20212,790,000 shares $9.35 million -24.8%6.6%4 $3.35 6/15/20213,710,000 shares $13.21 million -7.3%8.8%5.1 $3.56 5/28/20214,000,000 shares $14.96 million -2.7%9.4%5.2 $3.74 5/14/20214,110,000 shares $12.78 million -1.4%N/A4.4 $3.11 4/30/20214,170,000 shares $16.30 million No ChangeN/A3.7 $3.91 4/15/20214,170,000 shares $16.97 million -3.9%N/A2.9 $4.07 3/31/20214,340,000 shares $17.66 million +24.4%N/A2.9 $4.07 3/15/20213,490,000 shares $18.43 million +9.8%N/A1.9 $5.28 2/26/20213,180,000 shares $16.89 million -2.8%N/A1.8 $5.31 2/12/20213,270,000 shares $22.82 million -22.0%N/A1.9 $6.98 1/29/20214,190,000 shares $18.73 million +3.7%N/A2.7 $4.47 1/15/20214,040,000 shares $15.47 million +27.0%N/A3.1 $3.83 12/31/20203,180,000 shares $14.06 million +0.6%N/A2.9 $4.42 12/15/20203,160,000 shares $10.40 million -6.2%N/A3.3 $3.29 11/30/20203,370,000 shares $10.41 million +12.3%N/A5.4 $3.09 11/15/20203,000,000 shares $9.48 million -1.0%N/A4.2 $3.16 10/30/20203,030,000 shares $10.70 million +2.0%N/A3.4 $3.53 10/15/20202,970,000 shares $10.96 million -5.7%N/A3.3 $3.69 GNPX Short Interest - Frequently Asked Questions What is Genprex's current short interest? Short interest is the volume of Genprex shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 4,130,000 shares of GNPX short. 9.88% of Genprex's shares are currently sold short. Learn More on Genprex's current short interest. What is a good short interest percentage for Genprex? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.88% of Genprex's floating shares are currently sold short. Is Genprex's short interest increasing or decreasing? Genprex saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 4,130,000 shares, an increase of 49.6% from the previous total of 2,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genprex's float size? Genprex currently has issued a total of 42,905,000 shares. Some of Genprex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genprex currently has a public float of 41,790,000 shares. How does Genprex's short interest compare to its competitors? 9.88% of Genprex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genprex: Verrica Pharmaceuticals Inc. (4.18%), LAVA Therapeutics N.V. (0.67%), Grace Therapeutics, Inc. (2.07%), OnKure Therapeutics, Inc. (2.41%), Dyadic International Inc. (0.38%), Klotho Neurosciences, Inc. (4.84%), Jasper Therapeutics, Inc. (4.86%), Alterity Therapeutics Limited - Sponsored ADR (0.41%), X4 Pharmaceuticals, Inc. (13.23%), Elutia Inc. (0.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Genprex stock? Short selling GNPX is an investing strategy that aims to generate trading profit from Genprex as its price is falling. GNPX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genprex? A short squeeze for Genprex occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNPX, which in turn drives the price of the stock up even further. How often is Genprex's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNPX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Verrica Pharmaceuticals Short Squeeze LAVA Therapeutics Short Squeeze Grace Therapeutics Short Squeeze OnKure Therapeutics Short Squeeze Dyadic International Short Squeeze Klotho Neurosciences Short Squeeze Jasper Therapeutics Short Squeeze Alterity Therapeutics Short Squeeze X4 Pharmaceuticals Short Squeeze Elutia Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNPX) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex Please log in to your account or sign up in order to add this asset to your watchlist. Share Genprex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
